# Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT

> **NCT04622631** · — · UNKNOWN · sponsor: **Dr. Nayruz Knaana** · enrollment: 80 (estimated)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04622631
- **Lead sponsor:** Dr. Nayruz Knaana
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11
- **Primary completion:** 2022-01
- **Final completion:** 2023-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04622631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04622631, "Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04622631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*